Literature DB >> 12355312

The effect of levofloxacin concentration on the development and maintenance of antibiotic-resistant clones of Escherichia coli in chemostat culture.

G T Fleming1, D M McCarthy, N Colombet, J W Patching.   

Abstract

A levofloxacin-sensitive strain of Escherichia coli (broth MIC: 0.0625 mg x l(-1)) was grown in carbon-limited chemostat culture for 316 h (D=0.294 h(-1)). Hyperresistant strains isolated after 58 and 91 generations of culture retained a 16- to 47-fold increase in tolerance to levofloxacin during antibiotic-free serial batch and continuous culture (20 generations, glucose-limited, D=0.2 h(-1)). Isolates differed from the original strain in their maximum growth rates in the presence and absence of subinhibitory levels of levofloxacin, protein-banding profiles, and resistance to a range of antibiotics. Competition between resistant isolates and the original sensitive strain was studied in glucose-limited chemostat cultures (D=0.2 h(-1)). At levofloxacin concentrations less than 0.03 mg x l(-1), the sensitive strain outcompeted resistant isolates and displaced them from the culture, whereas the reverse was true at higher concentrations. These results have clinical and environmental implications for those administering levofloxacin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12355312     DOI: 10.1038/sj.jim.7000295

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  2 in total

1.  Modeling the Emergence of Antibiotic Resistance in the Environment: an Analytical Solution for the Minimum Selection Concentration.

Authors:  Ben K Greenfield; Shanna Shaked; Carl F Marrs; Patrick Nelson; Ian Raxter; Chuanwu Xi; Thomas E McKone; Olivier Jolliet
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  Continuous culture of Escherichia coli, under selective pressure by a novel antimicrobial complex, does not result in development of resistance.

Authors:  Lilit Tonoyan; Gerard T A Fleming; Ruairi Friel; Vincent O'Flaherty
Journal:  Sci Rep       Date:  2019-02-20       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.